C2i and Hitachi Launch First Automated Organoid Culture System in Hong Kong
Hong Kong based Centre for Immunology & Infection Limited (C2i), its spin-off C2iTech, and Japanese multinational conglomerate Hitachi have announced a strategic collaboration to develop 3D printed airway organoids for clinical applications. C2i also unveiled Hong Kong’s first automated organoid culture system, located at the Hong Kong Science Park (HKSTP). These joint efforts aim to enhance the efficiency, scalability, and standardization of organoid production, driving advancements in personalized medicine and regenerative therapies.